락토코커스 락티스

Lactococcus lactis strain Plasma activates plasmacytoid dendritic cells and mitigates common cold-like symptoms in healthy adults: a meta-analysis of individual participant data.

1. Front Immunol. 2025 Nov 6;16:1696989. doi: 10.3389/fimmu.2025.1696989. eCollection 2025. Lactococcus lactis strain Plasma activates plasmacytoid dendritic cells and mitigates common cold-like symptoms in healthy adults: a meta-analysis of individual participant data. Kato Y(1), Kobayashi K(1

Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome.

2. Nat Commun. 2020 May 25;11(1):2610. doi: 10.1038/s41467-020-16438-8. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome. Pasolli E(1)(2), De Filippis F(1)(2), Mauriello IE(1), Cumbo F(3), Walsh AM(4)(5), Leech J(4)(5), Cotter PD(4)(5), Segata N(3), E

The safety and efficacy of in situ vaccine FOLactis for advanced hepatic malignancies.

3. Vaccine. 2026 Apr 11;78:128377. doi: 10.1016/j.vaccine.2026.128377. Epub 2026 Feb 27. The safety and efficacy of in situ vaccine FOLactis for advanced hepatic malignancies. Zhou Z(1), Lu X(2), Hu L(1), Zhu S(3), Qi L(4), Zhu X(5), Shen J(6). Author information: (1)Comprehensive Cancer Center

[The effect of AntiAGE-Biom probiotic on metabolic features in individuals with type 2 diabetes].

4. Ter Arkh. 2025 Nov 11;97(10):859-866. doi: 10.26442/00403660.2025.10.203462. [The effect of AntiAGE-Biom probiotic on metabolic features in individuals with type 2 diabetes]. [Article in Russian; Abstract available in Russian from the publisher] Shestakova EA(1)(2), Nosova AV(1), Dzgoeva FK(1

12-week preoperative probiotic supplementation versus placebo: effects on inflammation, endotoxemia, adipokines, and gastrointestinal peptides in patients six months after bariatric surgery - a double-blind, randomized, placebo-controlled clinical trial.

5. Nutr J. 2025 Oct 9;24(1):156. doi: 10.1186/s12937-025-01217-2. 12-week preoperative probiotic supplementation versus placebo: effects on inflammation, endotoxemia, adipokines, and gastrointestinal peptides in patients six months after bariatric surgery - a double-blind, randomized, placebo-co

Correlation between equol production and intestinal microbiota after treatment with isoflavone, isoflavone plus probiotic and hormonal therapy in postmenopausal women: a pilot study.

6. Menopause. 2025 Jul 1;32(7):610-620. doi: 10.1097/GME.0000000000002544. Correlation between equol production and intestinal microbiota after treatment with isoflavone, isoflavone plus probiotic and hormonal therapy in postmenopausal women: a pilot study. Ribeiro AE(1), Monteiro NES(2), Costa

Acupuncture for hormonal readiness and gut microbiota in obese polycystic ovary syndrome: an open-label, randomized controlled trial.

7. Front Endocrinol (Lausanne). 2024 Dec 19;15:1509152. doi: 10.3389/fendo.2024.1509152. eCollection 2024. Acupuncture for hormonal readiness and gut microbiota in obese polycystic ovary syndrome: an open-label, randomized controlled trial. Wu T(#)(1), Xu G(#)(1)(2)(3), Hong X(#)(1)(3), Fan H(1)

Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

8. Nutrients. 2024 Jun 27;16(13):2055. doi: 10.3390/nu16132055. Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Potrykus M(1), Czaja-Stolc S(2), Stan

Efficacy of Lactococcus lactis subsp. lactis LY-66 and Lactobacillus plantarum PL-02 in Enhancing Explosive Strength and Endurance: A Randomized, Double-Blinded Clinical Trial.

9. Nutrients. 2024 Jun 18;16(12):1921. doi: 10.3390/nu16121921. Efficacy of Lactococcus lactis subsp. lactis LY-66 and Lactobacillus plantarum PL-02 in Enhancing Explosive Strength and Endurance: A Randomized, Double-Blinded Clinical Trial. Lee MC(1)(2), Hsu YJ(1), Chen MT(3), Kuo YW(4), Lin JH(

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.

10. BMC Med. 2024 Apr 23;22(1):170. doi: 10.1186/s12916-024-03379-y. A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial. Alkema M(1), Smit MJ(1), Marin-Mogollon C(#)(1), Totté K(#)(1), Teelen K(1), van Gemert GJ(1), van de Vegte-Bolmer M(1),

A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab.

11. Diabetologia. 2024 Jan;67(1):27-41. doi: 10.1007/s00125-023-06014-2. Epub 2023 Oct 2. A first-in-human, open-label Phase 1b and a randomised, double-blind Phase 2a clinical trial in recent-onset type 1 diabetes with AG019 as monotherapy and in combination with teplizumab. Mathieu C(1), Wied

Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial.

12. J Med Virol. 2023 Aug;95(8):e29035. doi: 10.1002/jmv.29035. Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial. Zhao Y(1), Zhang H(2), Zhao Z(3), Liu F(4), Dong M(2), Chen L(2)(5), Shen M(6), Luan Z(7), Zhang H(7), Wu J(7), Li C(8), Chen

[In Vitro Assessment of the Antimicrobial and Antibiofilm Efficacy of Chlorhexidine, EDTA, and NaOCl in Combination with Nisin Against Enterococcus faecalis Isolates].

13. Mikrobiyol Bul. 2025 Oct;59(4):437-451. doi: 10.5578/mb.20250419. [In Vitro Assessment of the Antimicrobial and Antibiofilm Efficacy of Chlorhexidine, EDTA, and NaOCl in Combination with Nisin Against Enterococcus faecalis Isolates]. [Article in Turkish] Abay Celkan İ(1), Özdemir FN(2), Bek

Combination therapy with nisin, urolithin B, and vincristine exhibits synergistic antiproliferative and pro-apoptotic effects against human lymphoma cells: evidence from proteomics.

14. Front Immunol. 2025 Sep 23;16:1664468. doi: 10.3389/fimmu.2025.1664468. eCollection 2025. Combination therapy with nisin, urolithin B, and vincristine exhibits synergistic antiproliferative and pro-apoptotic effects against human lymphoma cells: evidence from proteomics. Al-Khazaleh AK(1),

Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control.

15. Gut Microbes. 2025 Dec;17(1):2451081. doi: 10.1080/19490976.2025.2451081. Epub 2025 Jan 16. Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control. Ríos Colombo NS(1), Paul Ross R(1)(2), Hil

Synergistic antimicrobial effects of thiamine dilauryl sulphate combined with the heartwood extract of Pterocarpus marsupium and antifungal mechanism in their combination.

6. Lett Appl Microbiol. 2025 Jan 6;78(1):ovae139. doi: 10.1093/lambio/ovae139. Synergistic antimicrobial effects of thiamine dilauryl sulphate combined with the heartwood extract of Pterocarpus marsupium and antifungal mechanism in their combination. Inoue MM(1), Kurotaki H(1), Mizuhara N(2), Og

The Synergistic Antimicrobial Effect and Mechanism of Nisin and Oxacillin against Methicillin-Resistant Staphylococcus aureus.

14. Int J Mol Sci. 2023 Apr 3;24(7):6697. doi: 10.3390/ijms24076697. The Synergistic Antimicrobial Effect and Mechanism of Nisin and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Wang J(1)(2), Ma X(1), Li J(1), Shi L(1), Liu L(1), Hou X(1), Jiang S(1), Li P(1), Lv J(1), Han L(3)

In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens.

31. J Vet Med Sci. 2017 Sep 12;79(9):1472-1479. doi: 10.1292/jvms.17-0180. Epub 2017 Jul 29. In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens. Kitazaki K(1)(2), Koga S(3), Nagatoshi K(3), Kuwano K(4), Zendo T(5), Nakayama J(5), Sonomoto K(5), Ano H(6), Katamot

A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus.

48. Front Cell Infect Microbiol. 2017 Jun 30;7:290. doi: 10.3389/fcimb.2017.00290. eCollection 2017. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus. Haddad Kashani H(1), Fahimi H(2), Dasteh Goli Y(3), Moniri R(1). Author information: (

Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.

20. Peptides. 2013 Dec;50:19-23. doi: 10.1016/j.peptides.2013.09.014. Epub 2013 Oct 1. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics. Lebel G(1), Piché F, Frenette M, Gottschalk M, Grenier D. Author information: (1

Salt effect of nisin Z isolated from a marine fish on the growth inhibition of Streptococcus iniae, a pathogen of streptococcosis.

30. Biotechnol Lett. 2012 Feb;34(2):315-20. doi: 10.1007/s10529-011-0766-6. Epub 2011 Nov 1. Salt effect of nisin Z isolated from a marine fish on the growth inhibition of Streptococcus iniae, a pathogen of streptococcosis. Heo WS(1), Kim EY, Kim YR, Hossain MT, Kong IS. Author information: (1)

Detection of nisin expression by Lactococcus lactis using two susceptible bacteria to associate the effects of nisin with EDTA.

25. Appl Biochem Biotechnol. 2006 Spring;129-132:334-46. doi: 10.1385/abab:129:1:334. Detection of nisin expression by Lactococcus lactis using two susceptible bacteria to associate the effects of nisin with EDTA. Penna TC(1), Jozala AF, Gentille TR, Pessoa Júnior A, Cholewa O. Author informati

Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial.

37. J Neurogastroenterol Motil. 2022 Oct 30;28(4):642-654. doi: 10.5056/jnm21202. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Tri

Impact of Infectious Disease after Lactococcus lactis Strain Plasma Intake in Vietnamese Schoolchildren: A Randomized, Placebo-Controlled, Double-Blind Study.

13. Nutrients. 2022 Jan 27;14(3):552. doi: 10.3390/nu14030552. Impact of Infectious Disease after Lactococcus lactis Strain Plasma Intake in Vietnamese Schoolchildren: A Randomized, Placebo-Controlled, Double-Blind Study. Thu NN(1), Mai TT(1), Trang TTT(1), Tuan NA(1), Quyen TC(1), Hanh NL(1), Ho

The effects of fermented milk containing Lactococcus lactis subsp. cremoris FC on defaecation in healthy young Japanese women: a double-blind, placebo-controlled study.

7. Int J Food Sci Nutr. 2018 Sep;69(6):762-769. doi: 10.1080/09637486.2017.1417977. Epub 2018 Jan 16. The effects of fermented milk containing Lactococcus lactis subsp. cremoris FC on defaecation in healthy young Japanese women: a double-blind, placebo-controlled study. Ozaki K(1), Maruo T(1),

Nisin: harnessing nature's preservative for the future of food safety and beyond.

47. Crit Rev Food Sci Nutr. 2025;65(34):9045-9070. doi: 10.1080/10408398.2025.2517822. Epub 2025 Jun 18. Nisin: harnessing nature's preservative for the future of food safety and beyond. Wang X(1), Kang W(1), Li J(1), Deng Z(2), Gao J(1). Author information: (1)Key BioAI Synthetica Lab for Natu

Lactococcus lactis as an Effective Mucosal Vaccination Carrier: a Systematic Literature Review.

11. J Microbiol Biotechnol. 2025 Mar 7;35:e2411036. doi: 10.4014/jmb.2411.11036. Lactococcus lactis as an Effective Mucosal Vaccination Carrier: a Systematic Literature Review. Kesuma S(1)(2), Raras TYM(3), Winarsih S(4), Shimosato T(4)(5), Yurina V(4). Author information: (1)Doctoral Program in

The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review.

6. Probiotics Antimicrob Proteins. 2024 Aug;16(4):1313-1326. doi: 10.1007/s12602-023-10116-z. Epub 2023 Jun 30. The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review. Frey-Furtado L(1)(2)(3), Magalhães I(2)(3)(4), Azevedo MJ(#)(5)(6)(7)(8), Sampaio-Maia B(#)(1)(

Nisin-A lantibiotic with immunomodulatory properties: A review.

46. Peptides. 2021 Mar;137:170479. doi: 10.1016/j.peptides.2020.170479. Epub 2020 Dec 30. Nisin-A lantibiotic with immunomodulatory properties: A review. Małaczewska J(1), Kaczorek-Łukowska E(2). Author information: (1)Department of Microbiology and Clinical Immunology, Faculty of Veterinary Me